RNAC

6.1404.24%
TC

Timothy C. Barabe

Independent Director

Mr. Timothy C. Barabe, also known as Tim, M.B.A., is Director of HeartFlow Holding, Inc. Mr. Barabe serves as Independent Director of HeartFlow, Inc. since January 2022. He serves as an Independent Director of Cartesian Therapeutics, Inc. since July 2016. He serves as Board Member of Vigilant Biosciences, Inc. since November 2014. He served as the Chief Financial Officer and Executive Vice President and at Affymetrix Inc. from March 15, 2010 to June 28, 2013 and also served as its Principal Accounting Officer until June 28, 2013. He served as Director of Acer Therapeutics Inc. Mr. Barabe served led Affymetrix's financial functions as well as the treasury, Investor Relations and information technology departments. He served as the Chief Financial Officer and Principal Accounting Officer of Human Genome Sciences Inc., from July 10, 2006 to March 3, 2010 and from January 31, 2007 to March 3, 2010 respectively. He served as a Senior Vice President of Human Genome Sciences Inc., since July 2006 until March 3, 2010. He served as an UK Managing Director at Molnlycke Health Care., from September 2005 to June 2006 and its Chief Financial Officer from September 2004 to September 2005. He served as the Chief Financial Officer of Regent Medical Ltd., from 2004 to 2006. Mr. Barabe served as the Chief Financial Officer of Sandoz International GmbH. He served as the Chief Financial Officer of Sandoz Generics (the generic pharmaceutical subsidiary of Novartis) since May 2003. He served as Group Vice President of CIBA Vision Corporation. He was with Novartis AG from April 1982 to 2004 served in various capacities. He served as the Chief Financial Officer of CIBA Vision Corporation, a subsidiary of Novartis from 1993 to January 2002 and a Director of Corporate Finance at Ciba-Geigy Corporation. From February 2002 to April 2003, Mr. Barabe served as a Group Vice President and President of Specialty Lenses of CIBA Vision. He served as a Vice President of Planning, Information and Control at the Worldwide CIBA Vision Division. From 1982 to June 1993, he held various positions with Ciba Geigy, a predecessor firm to Novartis Ltd. He had been an Independent Director of Selecta Biosciences, Inc. since July 2016. He had been an Independent Director of Opexa Therapeutics, Inc. since March 19, 2014 until 2017. He served as Director of Veeva Systems Inc., since September 9, 2015 until June 23, 2021. Mr. Barabe served as an Independent Director at ArQule Inc. since November 2001 until January 16, 2020. He served as a Treasurer of Fernbank Natural History Museum. He serves as a Trustee of Fernbank Natural History Museum. He served as a Director of Autonomous Technologies Corp. since July 1993. He served as a Director of BioCure, Inc. from June 1998 to May 2003. Mr. Barabe holds a BBA in General Business and Finance from University of Massachusetts (Amherst) and an MBA in Finance from University of Chicago and studied in Harvard Business School in Business Administration and Management (2001).

Positions